Icahn Carl C Bausch Health Companies Inc. Transaction History
Icahn Carl C
- $7.75 Billion
- Q2 2025
A detailed history of Icahn Carl C transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Icahn Carl C holds 34,721,118 shares of BHC stock, worth $237 Million. This represents 2.99% of its overall portfolio holdings.
Number of Shares
34,721,118
Previous 34,721,118
-0.0%
Holding current value
$237 Million
Previous $225 Million
2.94%
% of portfolio
2.99%
Previous 3.02%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
252Shares Held
243MCall Options Held
2.44MPut Options Held
8.42M-
Goldentree Asset Management LP New York, NY34.3MShares$234 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$224 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$147 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$88.8 Million0.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$80.4 Million0.0% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.47B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...